Physician profile
Harim Im
NPI 1992585335
$1,344.41
in general payments reported to CMS, 2019-2025
14 companies · $830 in 2025
The $830 reported for 2025 was more than what 85% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $514 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $299.29 | 2024-2025 | Biomonitor, Acticor 7 Vr-T Dx, Selectra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.98 | 2024-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $160.77 | 2025 | Amvuttra |
| Janssen Pharmaceuticals, INC | $131.51 | 2024 | Xarelto |
| Scpharmaceuticals INC. | $121.86 | 2025 | |
| Kestra Medical Technology Services, INC. | $114.71 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $81.48 | 2024-2025 | |
| Imperative Care, INC | $43.85 | 2025 | Symphony Catheter |
| Amgen INC. | $31.08 | 2024 | Repatha |
| Baxter Healthcare | $29.86 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Abiomed | $29.04 | 2025 | |
| Merck Sharp & Dohme LLC | $22.88 | 2024 | Verquvo |
| Novo Nordisk INC | $18.11 | 2025 | Wegovy |
| Medtronic, INC. | $16.99 | 2025 | Avalus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harim Im listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.